gluten

Popular Big Pharma blood pressure drug linked to gluten sensitivity, Celiac disease

Sunday, July 01, 2012 by: Jonathan Benson, staff writer
Tags: blood pressure drugs, gluten, Celiac disease

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
Biologist explains how marijuana causes tumor cells to commit suicide
Companies begin planting microchips under employees' skin
NJ cops bust teenagers shoveling snow without a permit
Chemotherapy kills cancer patients faster than no treatment at all
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Whooping cough outbreak at Massachusetts high school affected only vaccinated students
Inuit Elders tell NASA Earth Axis Shifted
Vaccine flu shots still contain 25 micrograms mercury - 100 times the concentration of 'mercury-loaded' fish
Measles outbreak likely caused by vaccinated children, science shows
Baby formula is loaded with GMOs - Avoid these brands
Extreme trauma from male circumcision causes damage to areas of brain
Terminal stage IV lung cancer patient miraculously cured by cannabis oil
Costco stops selling antibiotic laden chicken in response to consumer demand
FDA cracks down Walmart, GNC, other companies selling supplements that do not contain the herbs on the label
McDonald's french fries found to contain Silly Putty ingredient and petroleum chemical

Delicious
(NaturalNews) Is it possible that the massive rise in diagnoses of gluten insensitivity and Celiac disease is in some way linked to the medications people are taking? A new study published online in the journal Mayo Clinic Proceedings seems to suggest so, having found that the popular blood pressure drug Benicar (olmesartan) often causes patients to develop symptoms of Celiac disease that later subside when the medication is ceased.

Dr. Joseph A. Murray, M.D., and his colleagues at the Mayo Clinic in Rochester, Minn., first made the observation after noting that 22 of the patients admitted to the center over a three-year period had symptoms of Celiac disease, but did not test positive for the condition in blood tests. Upon further investigation, the team determined that olmesartan was the likely culprit.

When the patients with Celiac symptoms stopped taking olmesartan, their symptoms largely disappeared, which suggests that the drug and potentially others in its class may be responsible for triggering allergic and gastrointestinal reactions. In fact, a followup investigation revealed that patients who took olmesartan sustained very serious intestinal damage as a result of the drug, and that this damage began to heal when they stopped taking it.

"There is no question that the report from the Mayo Clinic documenting that olmesartan has severe gastrointestinal adverse effects is of concern," said Dr. Franz Messerli, M.D., director of the hypertension program at St. Luke's - Roosevelt Hospital in New York City. "Olmesartan sales have exceeded $500 million a year in the U.S. alone and the drug, as with all ARBs (angiotensin receptor blockers), stands out because of its paucity of side effects."

Dr. Murray, author of the study, had actually reported these and other serious side effects associated with ARBs to the U.S. Food and Drug Administration (FDA) back in 2009. But the agency ignored the evidence and unilaterally decreed that the evidence was not definitive enough to verify a "statistically significant' association between Celiac disease symptoms and ARBs.

But the evidence speaks for itself, as experts suspect that ARBs inhibit transforming growth factor-beta (TGF-beta), an intestinal cytokine responsible for intestinal equilibrium, also known as homeostasis. By blocking TGF-beta, ARBs prevent the human gut from properly adapting to changing levels and ratios of various bacteria, both good and bad, which upsets digestion and leads to intestinal damage.

"The gut has to learn to tolerate a lot of different bacteria and TGF-beta is an important chemical messenger for that tolerance," said Dr. Murray to MedPage Today, noting that when patients stopped taking olmesartan, their TGF-beta levels appeared to normalize.

Sources for this article include:

http://www.medpagetoday.com/Cardiology/Hypertension/33414

http://abcnews.go.com

http://www.ncbi.nlm.nih.gov/pubmed/12904684

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.